Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 1
2024 1
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean federman m (127 results)?
Apixaban for Extended Treatment of Provoked Venous Thromboembolism.
Piazza G, Bikdeli B, Pandey AK, Krishnathasan D, Khairani CD, Bejjani A, Morrison RH, Hogan H, Rashedi S, Pfeferman M, Lou J, Fanikos J, Porio N, Rosenbaum L, Sobieszczyk P, Lan Z, Gerhard-Herman M, Campia U, Goldhaber SZ; HI-PRO Trial Investigators. Piazza G, et al. Among authors: pfeferman m. N Engl J Med. 2025 Sep 25;393(12):1166-1176. doi: 10.1056/NEJMoa2509426. Epub 2025 Aug 30. N Engl J Med. 2025. PMID: 40888734 Clinical Trial.
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Lang IM, Weitz JI, Goldhaber SZ, De Caterina R, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B. Rashedi S, et al. Among authors: pfeferman mb. J Am Coll Cardiol. 2025 Oct 7;86(14):1065-1087. doi: 10.1016/j.jacc.2025.07.061. J Am Coll Cardiol. 2025. PMID: 41033744 Review.
Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications.
Pfeferman MB, Rashedi S, Lip GYH, Weber C, O'Donoghue ML, Nissen S, Nicholls SJ, Natarajan P, Plutzky J, Libby P, Goldhaber SZ, Piazza G, Bikdeli B. Pfeferman MB, et al. Thromb Haemost. 2025 Nov;125(11):1069-1084. doi: 10.1055/a-2674-5114. Epub 2025 Aug 22. Thromb Haemost. 2025. PMID: 40845898 Free article. Review.
Predictors of venous thromboembolic events in hospitalized patients with COVID-19.
Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N, Bejjani A, Khairani CD, Davies J, Porio N, Assi AA, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq Z, Wei E, Zuluaga-Sánchez V, Zarghami M, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Campia U, Bikdeli B, Piazza G. Scimeca G, et al. Among authors: pfeferman mb. J Thromb Thrombolysis. 2025 Apr;58(4):485-496. doi: 10.1007/s11239-025-03078-2. Epub 2025 Mar 10. J Thromb Thrombolysis. 2025. PMID: 40064840
Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2).
Piazza G, Hurwitz S, Campia U, Bikdeli B, Lou J, Khairani CD, Bejjani A, Snyder JE, Pfeferman M, Barns B, Rizzo S, Glezer A, Goldhaber SZ. Piazza G, et al. Among authors: pfeferman m. Thromb Res. 2023 Jul;227:1-7. doi: 10.1016/j.thromres.2023.05.006. Epub 2023 May 11. Thromb Res. 2023. PMID: 37182298 Free article. Clinical Trial.
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19.
Bikdeli B, Krishnathasan D, Khairani CD, Bejjani A, Davies J, Porio N, Tristani A, Armero A, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Ortiz-Rios MD, Zuluaga-Sánchez V, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Grandone E, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Lan Z, Piazza G; CORONA-VTE-Network Investigators. Bikdeli B, et al. Among authors: pfeferman mb. Thromb Res. 2024 May;237:209-215. doi: 10.1016/j.thromres.2024.02.021. Epub 2024 Apr 6. Thromb Res. 2024. PMID: 38677791 Free article.
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial.
Bikdeli B, Hogan H, Morrison RB, Fanikos J, Campia U, Barns BM, Pfeferman MB, Snyder JE, Khairani CD, Goldhaber SZ, Piazza G. Bikdeli B, et al. Among authors: pfeferman mb. Thromb Haemost. 2022 Jun;122(6):1061-1070. doi: 10.1055/a-1646-2244. Epub 2021 Oct 31. Thromb Haemost. 2022. PMID: 34530470 Clinical Trial.
12 results